Medical News

RSS

Democrats appeal for health legislation to honor Kennedy

Democrats "evoked memories" of Sen. Edward Kennedy to urge health care reform, as many acknowledged that his absence leaves a leadership gap.

1 Sep 2009

Psychological therapy for breast cancer patients reduces blood inflammation levels

A psychological intervention for newly diagnosed breast cancer patients with symptoms of depression not only relieves patients' depression but also lowers indicators of inflammation in the blood.

1 Sep 2009

Edwards Lifesciences completes patient enrollment for transcatheter heart valve study

Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, today announced completion of enrollment in its 1,040-patient randomized controlled Investigational Device Exemption (IDE) study of the Edwards SAPIEN transcatheter heart valve.

1 Sep 2009

FDA approves Hospira's six new vial presentations of heparin

Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's applications for six new presentations of therapeutic heparin in single- and multiple-dose vials.

1 Sep 2009

Research study to identify the appropriate amount of DHA required for promoting optimal heart health

A team of French scientists have found the dose of DHA (docosahexaenoic acid) that is "just right" for preventing cardiovascular disease in healthy men. In a research report appearing in the September 2009 print issue of The FASEB Journal, the scientists show that a 200 mg dose of DHA per day is enough to affect biochemical markers that reliably predict cardiovascular problems, such as those related to aging, atherosclerosis, and diabetes. This study is the first to identify how much DHA is necessary to promote optimal heart health.

1 Sep 2009

H1N1 cases on decline in Southern Hemisphere, WHO says

The number of H1N1 (swine) flu cases are steadily declining in the Southern Hemisphere as the region's flu season comes to an end, the WHO said Friday, the Associated Press reports (Engeler, 8/29).

1 Sep 2009

Also in Global Health news: Flu, cholera in PNG; improving life awards; HIV/AIDS in Rwanda; men and maternal/child health; MDR-TB in India

"Twin outbreaks of a flu-like illness and dysentery in a remote region of Papua New Guinea have killed 47 people and infected another 2,000 villagers, a senior medical official said Monday," Agence France-Presse reports. According to provincial health adviser Doctor Theo Likei, the WHO has collected and is testing samples of the virus from the "stricken villages" (8/31). Additionally, the country is experiencing a cholera outbreak - "the first time the disease has officially been confirmed in the country," the BBC reports (Mercer, 8/31).

1 Sep 2009

Chemotherapy affects sleep-wake activity rhythms of breast cancer patients

A study in the Sept.1 issue of the journal Sleep shows that the sleep-wake activity rhythms of breast cancer patients are impaired during the administration of chemotherapy. Results indicate that the first cycle of chemotherapy is associated with a temporary disruption of these rhythms, while repeated administration of chemotherapy results in progressively worse and more enduring impairments.

1 Sep 2009

Low level exposure to carbon dioxide leads to increased risk of hospitalization in older people

Exposure to carbon monoxide, even at levels well below national limits, is associated with an increased risk of hospitalization for the elderly with heart problems, according to a study published today in Circulation: Journal of the American Heart Association.

1 Sep 2009

Hospital executives worry about reform uncertainties

Federal authorities are conducting a thorough investigation of Saint Francis Hospital and Medical Care Center in Connecticut. Hartford Business Journal Online reports: "The failure of an oxygenator — medical equipment often used in cardiac surgery in conjunction with a heart-lung machine — triggered a complaint by the state of Connecticut to the Centers for Medicare & Medicaid [Services] (CMS), said Roseanne Pawelec, an agency spokeswoman.

1 Sep 2009

Hospital executives worry about reform uncertainties

Hospital executives worry about uncertainties in reform. The Washington Post reports: "Anxiety is running high among hospital executives as they ponder the ever-changing proposals on Capitol Hill. Wary of changes to payment formulas and fiercely protective of their franchise, industry groups are spending millions to lobby Congress.

1 Sep 2009

Explainers and fact checks on health reform bills

Several news organizations published explainers on health reform.

1 Sep 2009

Burger chain invests in health care insurance, sees gains

A burger chain pays more for employees' health care insurance and, in turn, has reaped significant gains. The Wall Street Journal reports: "Four years ago, executives of Burgerville, a regional restaurant chain, agreed to pay at least 90% of health-care premiums for hourly employees who work at least 20 hours a week."

1 Sep 2009

Obama returns from vacation facing tough health overhaul odds, but has some strengths

"President Obama still has stronger prospects for achieving his health policy goals than surface impressions of the Congressional recess indicate," the New York Times reports.

1 Sep 2009

OHSU study reveals that fluoroquinolones may cause double vision

Highlights of September's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy), include a 2009 review by the Academy of the safety and efficacy of a widely used corneal transplant procedure and a warning about an unusual but serious reaction to systemic fluroquinolones, a class of antibiotics used to treat a variety of bacterial infections.

1 Sep 2009

Mitoxantrone is highly efficient in suppressing multiple sclerosis

According to data supplied by the German Multiple Sclerosis Society's national MS register (DMSG - Deutsche Multiple Sklerose Gesellschaft), up to 10% of German MS patients have been treated with mitoxantrone in the past few years.

1 Sep 2009

New Vice President for Bioanalytical Development lab appointed by Cytovance Biologics

Cytovance Biologics LLC, a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from mammalian cell culture, today announced the addition of Dr. Jeffrey Su as Vice President of Bioanalytical Development to its diverse and growing scientific staff. Dr. Su will head up the state of the art Bioanalytical Development laboratory supporting existing and new client needs.

1 Sep 2009

Medical News

Democrats appeal for health legislation to honor Kennedy

Psychological therapy for breast cancer patients reduces blood inflammation levels

Edwards Lifesciences completes patient enrollment for transcatheter heart valve study

FDA approves Hospira's six new vial presentations of heparin

Research study to identify the appropriate amount of DHA required for promoting optimal heart health

H1N1 cases on decline in Southern Hemisphere, WHO says

Also in Global Health news: Flu, cholera in PNG; improving life awards; HIV/AIDS in Rwanda; men and maternal/child health; MDR-TB in India

Chemotherapy affects sleep-wake activity rhythms of breast cancer patients

Low level exposure to carbon dioxide leads to increased risk of hospitalization in older people

Hospital executives worry about reform uncertainties

Hospital executives worry about reform uncertainties

Explainers and fact checks on health reform bills

Burger chain invests in health care insurance, sees gains

Obama returns from vacation facing tough health overhaul odds, but has some strengths

OHSU study reveals that fluoroquinolones may cause double vision

Mitoxantrone is highly efficient in suppressing multiple sclerosis

New Vice President for Bioanalytical Development lab appointed by Cytovance Biologics

Drug stores consider how reform efforts may affect drug stores

Lawmakers sound off on health care reform

Mistrust in health care system could impact patients' health and health care costs

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Latest News